ANI Pharmaceuticals, Inc. – NASDAQ:ANIP

ANI Pharmaceuticals stock price today

$89.9
+35.48
+65.23%
Financial Health
0
1
2
3
4
5
6
7
8
9

ANI Pharmaceuticals stock price monthly change

-14.31%
month

ANI Pharmaceuticals stock price quarterly change

-14.31%
quarter

ANI Pharmaceuticals stock price yearly change

-1.29%
year

ANI Pharmaceuticals key metrics

Market Cap
1.11B
Enterprise value
868.92M
P/E
-12.75
EV/Sales
2.74
EV/EBITDA
36.27
Price/Sales
1.99
Price/Book
1.86
PEG ratio
-1.23
EPS
1.70
Revenue
517.46M
EBITDA
112.28M
Income
35.54M
Revenue Q/Q
28.69%
Revenue Y/Y
44.26%
Profit margin
-15.14%
Oper. margin
-8.13%
Gross margin
56.13%
EBIT margin
-8.13%
EBITDA margin
21.7%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

ANI Pharmaceuticals stock price history

ANI Pharmaceuticals stock forecast

ANI Pharmaceuticals financial statements

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP): Profit margin
Jun 2023 116.54M 6.24M 5.36%
Sep 2023 131.82M 9.94M 7.54%
Dec 2023 131.65M 1.15M 0.88%
Mar 2024 137.43M 18.20M 13.25%
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP): Analyst Estimates
Mar 2024 137.43M 18.20M 13.25%
Sep 2025 140.46M 21.33M 15.19%
Oct 2025 144.45M 26.80M 18.55%
Dec 2025 149.21M 27.96M 18.74%
  • Analysts Price target

  • Financials & Ratios estimates

0%
Yield TTM
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP): Payout ratio
Payout ratio 0%
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP): Dividend Yield
2019
2020
2021 0.03%
2022 0.25%
2023 0.16%
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP): Debt to assets
Jun 2023 859341000 424.86M 49.44%
Sep 2023 889914000 435.20M 48.9%
Dec 2023 904422000 471.67M 52.15%
Mar 2024 914524000 462.56M 50.58%
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP): Cash Flow
Jun 2023 20.62M -6.82M 80.15M
Sep 2023 32.16M -4.55M 3.75M
Dec 2023 44.74M -4.77M -11.91M
Mar 2024 18.26M 8.93M -19.72M

ANI Pharmaceuticals alternative data

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP): Employee count
Aug 2023 600
Sep 2023 600
Oct 2023 600
Nov 2023 600
Dec 2023 600
Jan 2024 600
Feb 2024 600
Mar 2024 642
Apr 2024 642
May 2024 642
Jun 2024 642
Jul 2024 642

ANI Pharmaceuticals other data

45.28% -17.59%
of ANIP is owned by hedge funds
7.36M -2.88M
shares is hold by hedge funds

ANI Pharmaceuticals, Inc. (NASDAQ:ANIP): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 50250
Feb 2024 0 250
Mar 2024 0 159632
Apr 2024 0 70250
May 2024 0 90919
Jun 2024 0 78235
Jul 2024 0 70250
Aug 2024 0 250
Sep 2024 0 250
Oct 2024 0 250
Nov 2024 0 40231
Dec 2024 0 1000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
DAVIS KRISTA officer: SVP, CHIEF HR OFFICER
Common Stock 1,000 $60 $60,000
Option
LALWANI NIKHIL director, officer.. Common Stock 30,000 $29 $870,000
Sale
LALWANI NIKHIL director, officer.. Common Stock 30,000 $57.95 $1,738,500
Sale
LALWANI NIKHIL director, officer.. Common Stock 3,481 $58.3 $202,942
Option
LALWANI NIKHIL director, officer.. Stock Option (right to buy) 30,000 $29 $870,000
Sale
MUTZ CHRISTOPHER officer: HEAD OF RARE DISEASE
Common Stock 6,500 $57.7 $375,050
Sale
COOK MEREDITH officer: SR. VP, GENERAL COUNSE..
Common Stock 250 $61.36 $15,340
Sale
COOK MEREDITH officer: SR. VP, GENERAL COUNSE..
Common Stock 250 $57.19 $14,298
Sale
COOK MEREDITH officer: SR. VP, GENERAL COUNSE..
Common Stock 250 $56.82 $14,205
Sale
COOK MEREDITH officer: SR. VP, GENERAL COUNSE..
Common Stock 250 $59.62 $14,905
Thursday, 26 December 2024
zacks.com
Wednesday, 18 December 2024
zacks.com
Monday, 2 December 2024
zacks.com
Tuesday, 26 November 2024
globenewswire.com
zacks.com
Wednesday, 20 November 2024
zacks.com
Thursday, 14 November 2024
zacks.com
Friday, 8 November 2024
seekingalpha.com
zacks.com
zacks.com
globenewswire.com
Monday, 4 November 2024
globenewswire.com
Friday, 1 November 2024
zacks.com
Wednesday, 30 October 2024
globenewswire.com
Friday, 25 October 2024
globenewswire.com
Thursday, 24 October 2024
globenewswire.com
Monday, 21 October 2024
zacks.com
Thursday, 17 October 2024
zacks.com
Wednesday, 16 October 2024
zacks.com
Tuesday, 15 October 2024
zacks.com
Friday, 11 October 2024
benzinga.com
seekingalpha.com
Wednesday, 9 October 2024
zacks.com
Friday, 27 September 2024
zacks.com
Thursday, 26 September 2024
globenewswire.com
Monday, 16 September 2024
globenewswire.com
globenewswire.com
Friday, 13 September 2024
globenewswire.com
Wednesday, 11 September 2024
globenewswire.com
Tuesday, 10 September 2024
globenewswire.com
  • What's the price of ANI Pharmaceuticals stock today?

    One share of ANI Pharmaceuticals stock can currently be purchased for approximately $89.9.

  • When is ANI Pharmaceuticals's next earnings date?

    Unfortunately, ANI Pharmaceuticals's (ANIP) next earnings date is currently unknown.

  • Does ANI Pharmaceuticals pay dividends?

    No, ANI Pharmaceuticals does not pay dividends.

  • How much money does ANI Pharmaceuticals make?

    ANI Pharmaceuticals has a market capitalization of 1.11B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 53.87% to 486.82M US dollars.

  • What is ANI Pharmaceuticals's stock symbol?

    ANI Pharmaceuticals, Inc. is traded on the NASDAQ under the ticker symbol "ANIP".

  • What is ANI Pharmaceuticals's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of ANI Pharmaceuticals?

    Shares of ANI Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are ANI Pharmaceuticals's key executives?

    ANI Pharmaceuticals's management team includes the following people:

    • Mr. Stephen P. Carey Senior Vice President of Fin. & Chief Financial Officer(age: 54, pay: $877,180)
    • Mr. Nikhil Lalwani Pres, Chief Executive Officer & Director(age: 47, pay: $844,150)
    • Mr. James G. Marken Senior Vice President of Operations & Product Devel.(age: 62, pay: $715,620)
  • How many employees does ANI Pharmaceuticals have?

    As Jul 2024, ANI Pharmaceuticals employs 642 workers.

  • When ANI Pharmaceuticals went public?

    ANI Pharmaceuticals, Inc. is publicly traded company for more then 25 years since IPO on 5 May 2000.

  • What is ANI Pharmaceuticals's official website?

    The official website for ANI Pharmaceuticals is anipharmaceuticals.com.

  • Where are ANI Pharmaceuticals's headquarters?

    ANI Pharmaceuticals is headquartered at 210 Main Street West, Baudette, MN.

  • How can i contact ANI Pharmaceuticals?

    ANI Pharmaceuticals's mailing address is 210 Main Street West, Baudette, MN and company can be reached via phone at +218 6343500.

ANI Pharmaceuticals company profile:

ANI Pharmaceuticals, Inc.

anipharmaceuticals.com
Exchange:

NASDAQ

Full time employees:

642

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

210 Main Street West
Baudette, MN 56623

CIK: 0001023024
ISIN: US00182C1036
CUSIP: 00182C103